Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Aastrom Biosciences Inc. (ASTM)

The PureGen osteoprogenitor cell allograft facilitates bone fusion,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
EZ2 Member Profile
Member Level Grandfathered Member
Followed By 191
Posts 174,335
Boards Moderated 7
Alias Born 03/31/01
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/15/2014 1:27:15 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/15/2014 1:26:38 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/14/2014 3:01:19 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/14/2014 12:49:31 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 8/6/2014 4:02:05 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/11/2014 5:05:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/27/2014 5:45:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/24/2014 12:56:45 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/24/2014 9:14:17 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/24/2014 9:08:42 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/16/2014 2:42:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/16/2014 2:42:42 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 6/16/2014 2:39:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/16/2014 8:52:05 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/13/2014 2:27:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/4/2014 8:45:20 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/2/2014 8:45:48 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/19/2014 12:08:04 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/19/2014 12:06:09 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/16/2014 9:28:50 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/16/2014 9:28:15 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2014 4:12:38 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/12/2014 5:06:52 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/12/2014 8:39:25 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/12/2014 8:38:33 AM
EZ2 Member Level Grandfathered Member Tuesday, 10/05/10 09:40:31 AM
Re: mkendra post# 2573
Post # of 4215 
Quote:
The PureGen osteoprogenitor cell allograft facilitates bone fusion, and is marketed exclusively by Alphatec Spine.

PureGen is an adult stem cell that provides cellular and growth factors needed for osteogenesis, without the potential complications of autograft.

Applied at the site of a musculoskeletal defect, PureGen mimics the regenerative environment of youthful tissues by increasing the concentration of stem cells available to repair tissue and build bone.


“There are those who don’t know and those who don’t know they don’t know.”

John Kenneth Galbraith
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist